Paramesu Biotech To Raise Rs 600 Cr Via IPO—SEBI Approves Listing; Public Listing Soon

By /



Paramesu Biotech’s IPO aims to raise ₹600 crore for expansion and debt repayment, showcasing strong financial performance and growth potential.



Source link

Related Posts

Leave a Comment

Your email address will not be published. Required fields are marked *

Review Your Cart
0
Add Coupon Code
Subtotal
Checkout

 
Scroll to Top